Hyperactivity Clinical Trials in New York, New York
4 recruitingNew York, New York
Showing 1–4 of 4 trials
Recruiting
Phase 4
An Open-Label Treatment With Randomization Observation, Investigator-Initiated Study, on the Duration and Efficacy of Jornay PM (Methylphenidate Hydrochloride Extended-Release Capsules) on Adult ADHD Symptoms and Executive Function and Emotional Regulation Throughout the Day Into Early Evening
Attention Deficit Hyperactivity Disorder
NYU Langone Health30 enrolled1 locationNCT06577779
Recruiting
Phase 4
Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD
Attention Deficit Hyperactivity Disorder
Supernus Pharmaceuticals, Inc.286 enrolled47 locationsNCT04781140
Recruiting
Phase 4
Carboxylesterase 1 Genetic Variation and Methylphenidate in ADHD
Attention Deficit Hyperactivity DisorderADHD
Icahn School of Medicine at Mount Sinai500 enrolled4 locationsNCT03781752
Recruiting
Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Attention Deficit Hyperactivity DisorderADHD
Icahn School of Medicine at Mount Sinai44 enrolled1 locationNCT03781765